Facebook Friday 4/12/2020 – Nutrition Q&A with Erin Laing

Overview

This week, as a follow-up to our recent webinar on Nutrition and NETs, we were delighted to welcome Specialist NET Dietitian, Erin Laing, who kindly agreed to join us for a Q&A session with our Facebook Private Discussion Group!
For those who haven’t watched the webinar, it’s worth doing this first (see https://youtu.be/qHbig9ocOXk).

Notes:
Neuroendocrine Cancer Australia resources:
Nutrition and NETs booklet: https://neuroendocrine.org.au/wp-content/uploads/2020/02/UF_Nutirtion_V2.pdf
Vitamins and Mineral Deficiencies factsheet: https://neuroendocrine.org.au/wp-content/uploads/2020/02/181128-UFD-Factsheet02-Vitamins.pdf
Managing Diarrhoea factsheet: https://neuroendocrine.org.au/wp-content/uploads/2020/02/190801b-UFD-Factsheet3-Diarrhoea-Final.pdf
Food and Symptom Diary: https://neuroendocrine.org.au/wp-content/uploads/2020/06/N5058-NECA_NETs-Food-Symptom-Diary-v1.pdf

To contact Kate, email NETNurse@neuroendocrine.org.au or call 1300 287 363.

To support Kate’s in her virtual Melbourne Marathon event:
https://fundraise.neuroendocrine.org.au/event/march4nets/home

This video was originally broadcast into our Facebook Private Discussion Group. If you are affected by NETs (either as a patient or carer) and in Australia, you’re welcome to join this group – www.facebook.com/groups/472805285594/ (once you click on “Join Group”, you will be guided to answer three questions, so we can approve your membership). Our Carers group is at www.facebook.com/groups/797093257354706

Please note that the information provided in this video is general, and not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your own health or a medical concern.

Jump to section

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.